Location History:
- Tranbjerg J., DK (2008)
- Tranbjerg, DK (2014 - 2022)
Company Filing History:
2 out of 38 
2 out of 4 
1 out of 60 
Years Active: 2008-2025
Title: The Innovative Contributions of Peter Kristensen
Introduction
Peter Kristensen is a notable inventor based in Tranbjerg, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of 5 patents, Kristensen's work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
Among his latest patents are innovative antibodies against YKL-40. The first patent describes antibodies capable of binding murine and/or human YKL-40, along with compositions that include these antibodies. This invention is particularly relevant for treating diseases such as cancer, either alone or in combination with other anti-cancer agents. Another patent focuses on YKL-40 antibodies that are suitable for multiple purposes, including the detection of YKL-40 in various medical contexts.
Career Highlights
Throughout his career, Peter Kristensen has worked with prominent companies in the biotechnology sector, including Domantis Limited and Bio-y A/S. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in antibody development.
Collaborations
Kristensen has collaborated with esteemed colleagues such as Jean-Luc Jestin and Gregory Paul Winter. These partnerships have further enhanced his research capabilities and broadened the scope of his innovative work.
Conclusion
Peter Kristensen's contributions to the field of biotechnology, particularly through his patents on YKL-40 antibodies, demonstrate his commitment to advancing medical science. His work has the potential to lead to significant improvements in the treatment of various diseases.